We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHC
551
Diversified Healthcare Trust
DHC
$2.15B
$13.6K ﹤0.01%
2,800
+62
+2% +$281
ZLAB icon
552
Zai Lab
ZLAB
$2.07B
$13.5K ﹤0.01%
768
-261
-25% -$6.11K
IVVD icon
553
Invivyd
IVVD
$160M
$13.5K ﹤0.01%
+5,446
New +$11.3K
AIV
554
Aimco
AIV
$377M
$13.3K ﹤0.01%
2,246
-11
-0.5% -$66
IONQ icon
555
IonQ
IONQ
$11.9B
$12.8K ﹤0.01%
+286
New +$16K
LYEL icon
556
Lyell Immunopharma
LYEL
$318M
$12.8K ﹤0.01%
416
+3
+0.7% +$67
CMPS
557
Compass Pathways
CMPS
$1.47B
$12.8K ﹤0.01%
1,851
-122
-6% -$744
VTYX
558
DELISTED
Ventyx Biosciences
VTYX
$12.7K ﹤0.01%
+1,402
New +$10.5K
MGTX icon
559
MeiraGTx Holdings
MGTX
$1.08B
$12.6K ﹤0.01%
1,580
-151
-9% -$1.25K
PRME icon
560
Prime Medicine
PRME
$547M
$12.3K ﹤0.01%
3,547
-215
-6% -$956
KROS icon
561
Keros Therapeutics
KROS
$197M
$12.2K ﹤0.01%
598
-272
-31% -$4.77K
FULC icon
562
Fulcrum Therapeutics
FULC
$241M
$12K ﹤0.01%
+1,062
New +$10.8K
CGEM icon
563
Cullinan Oncology
CGEM
$1.06B
$12K ﹤0.01%
1,160
-91
-7% -$821
CRVS icon
564
Corvus Pharmaceuticals
CRVS
$1.1B
$11.3K ﹤0.01%
1,466
-137
-9% -$1.08K
PACB icon
565
Pacific Biosciences
PACB
$435M
$11.1K ﹤0.01%
5,932
-530
-8% -$1.02K
NXRT
566
NexPoint Residential Trust
NXRT
$689M
$10.9K ﹤0.01%
361
+5
+1% +$153
IRWD icon
567
Ironwood Pharmaceuticals
IRWD
$586M
$10.8K ﹤0.01%
3,196
-191
-6% -$496
SAFE
568
Safehold
SAFE
$1.17B
$10.6K ﹤0.01%
773
+12
+2% +$171
WSR
569
DELISTED
Whitestone REIT
WSR
$10.6K ﹤0.01%
761
+36
+5% +$464
DSGN icon
570
Design Therapeutics
DSGN
$751M
$10.5K ﹤0.01%
1,118
-95
-8% -$744
ABSI icon
571
Absci
ABSI
$1.17B
$10.3K ﹤0.01%
2,955
-262
-8% -$955
NKE icon
572
Nike
NKE
$64.1B
$10.2K ﹤0.01%
+160
New +$10.4K
PRTA icon
573
Prothena Corp
PRTA
$448M
$10.1K ﹤0.01%
1,057
-98
-8% -$998
VNDA icon
574
Vanda Pharmaceuticals
VNDA
$304M
$10.1K ﹤0.01%
1,140
-113
-9% -$622
ZVRA icon
575
Zevra Therapeutics
ZVRA
$578M
$9.91K ﹤0.01%
1,106
-102
-8% -$965
21 22
23
24 25

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.